Latest Breaking News On - Sosa navarro - Page 3 : comparemela.com

Cellectis Reports Financial Results for First Quarter 2024

Cellectis Reports Financial Results for First Quarter 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaUnited kingdomNew yorkFrance generalPatricia sosa navarroBing wangArthur strilAshleyr robinsonMarc dunoyerPascalyne wilsonAllogeneic car development programsResearch planCellectis the company euronext growthGroup shareInternational financial reporting standards

Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024

NEW YORK, May 27, 2024 Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will.

New yorkUnited statesFrance generalNorth carolinaPascalyne wilsonAshleyr robinsonArthur strilPatricia sosa navarroCellectis the company euronext growthEuronext growthNasdaq global marketSosa navarroInterim chief financial officerLifesci advisors

Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca

Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06, 2024 Cellectis a clinical-stage biotechnology.

France generalNorth carolinaUnited statesNew yorkPatricia sosa navarroPascalyne wilsonArthur strilAshleyr robinsonMarc dunoyerFrench ministry of economyEuronext growthFrench ministryAdditional investmentTyrell riversNasdaq global marketSosa navarro

Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca

Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNorth carolinaFrance generalArthur strilPascalyne wilsonPatricia sosa navarroAshleyr robinsonMarc dunoyerFrench ministry of economyAnnounces completionAdditional equity investmentEuronext growthFrench ministryAdditional investmentTyrell rivers

Cellectis Appoints Arthur Stril as Interim Chief Financial Officer

NEW YORK, May 02, 2024 Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the.

North carolinaUnited statesFrance generalNew yorkUnited kingdomPatricia sosa navarroBing wangAshleyr robinsonPascalyne wilsonArthur strilCorporate developmentSecurities exchange commissionCellectis the company euronext growthCambridge universityEuropean commission directorateUniversity of paris